| Ngure, Kenneth |
NCT06046053: MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films |
|
|
| Completed | 1 | 100 | US, RoW | Placebo Vaginal Film with Square Corners, Placebo Vaginal Film with Rounded Corners | Rohan, Lisa, PhD, United States Agency for International Development (USAID) | Safety, Acceptability, Usability | 12/24 | 12/24 | | |
| Completed | N/A | 211 | RoW | Formal peer PrEP referral + HIVST delivery | Fred Hutchinson Cancer Center, National Institute of Mental Health (NIMH) | HIV Prevention | 06/24 | 08/24 | | |
| Recruiting | N/A | 5944 | RoW | Client-sustained delivery of pharmacy PrEP/PEP, Implementor-sustained delivery of pharmacy PrEP/PEP, Counselor-supported delivery of pharmacy PrEP/PEP, Referral to clinic-based PrEP/PEP | Fred Hutchinson Cancer Center, Kenya Medical Research Institute, Jhpiego | Hiv | 06/25 | 06/25 | | |
| Selepe, Pearl |
INSIGHT, NCT05746065: A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African Women |
|
|
| Completed | N/A | 3087 | RoW | PrEP, Truvada | University of Washington, Bill and Melinda Gates Foundation | HIV Infections | 08/23 | 08/23 | | |
| Selepe, Raesibe AP |
NCT05118490: Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients |
|
|
| Recruiting | 4 | 1000 | RoW | Daily rifapentine and isoniazid for 4 weeks, Weekly rifapentine and isoniazid for 12 weeks | The Aurum Institute NPC, Johns Hopkins University | HIV Seropositivity, Tuberculosis, Household Contact | 10/24 | 12/24 | | |
CoTeT, NCT05459532: A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa |
|
|
| Recruiting | 3 | 4000 | RoW | Molnupiravir 200 mg | University of Witwatersrand, South Africa, Bill and Melinda Gates Foundation | COVID-19 | 07/24 | 07/27 | | |
AUR1-8-341, NCT05515042: Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults. |
|
|
| Active, not recruiting | 2 | 694 | RoW | Ad26.COV2.S (VAC31518, JNJ-78436735) Vaccine, SARS-CoV-2 rS (CovovaxTM), BNT162b2 (Pfizer) | The Aurum Institute NPC, Coalition for Epidemic Preparedness Innovations | COVID-19 | 06/24 | 12/24 | | |
NCT06046053: MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films |
|
|
| Completed | 1 | 100 | US, RoW | Placebo Vaginal Film with Square Corners, Placebo Vaginal Film with Rounded Corners | Rohan, Lisa, PhD, United States Agency for International Development (USAID) | Safety, Acceptability, Usability | 12/24 | 12/24 | | |
| Ndlovu, Nkosiphile |
| Recruiting | 1 | 100 | US, RoW | Placebo Intravaginal Ring A, Placebo Intravaginal Ring B | University of Pittsburgh, United States Agency for International Development (USAID), Oak Crest Institute of Science | Safety, Acceptability | 02/25 | 12/25 | | |
NCT06046053: MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films |
|
|
| Completed | 1 | 100 | US, RoW | Placebo Vaginal Film with Square Corners, Placebo Vaginal Film with Rounded Corners | Rohan, Lisa, PhD, United States Agency for International Development (USAID) | Safety, Acceptability, Usability | 12/24 | 12/24 | | |
NCT04778527: A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention |
|
|
| Active, not recruiting | N/A | 96 | RoW | Dual Prevention Pill, DPP, PrEP tablet and a COC as two separate tablets, Truvada, Zinnia F | Population Council | HIV Infections | 01/24 | 01/24 | | |
| Makkan, Heeran |
NCT06046053: MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films |
|
|
| Completed | 1 | 100 | US, RoW | Placebo Vaginal Film with Square Corners, Placebo Vaginal Film with Rounded Corners | Rohan, Lisa, PhD, United States Agency for International Development (USAID) | Safety, Acceptability, Usability | 12/24 | 12/24 | | |
| Thaver, Lucica D |
| Recruiting | 3 | 8000 | RoW | Azithromycin Oral Tablet, Placebo oral tablet | Population Health Research Institute | HIV Disease Progression | 05/28 | 08/28 | | |
